Inventor
NGUYEN-BA NGHE
CA32 patents
⚠️ This page may combine multiple inventors who share the name “NGUYEN-BA NGHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IAF BIOCHEM INT
18 patentsUS5047407ASep 10, 1991
2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT240 citations99
US5041449AAug 20, 1991
4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
IAF BIOCHEM INT170 citations98
US5466806ANov 14, 1995
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT123 citations97
US5270315ADec 14, 1993
4-(purinyl bases)-substituted-1,3-dioxlanes
IAF BIOCHEM INT115 citations97
US5151426ASep 29, 1992
2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT57 citations96
US6175008B1Jan 16, 2001
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT37 citations95
US6005107ADec 21, 1999
Antiviral compounds
IAF BIOCHEM INT43 citations95
US5955610ASep 21, 1999
Antiviral compounds
IAF BIOCHEM INT51 citations95
US5684164ANov 4, 1997
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT60 citations95
US6444656B1Sep 3, 2002
Antiviral phosphonate nucleotides
IAF BIOCHEM INT47 citations92
US6194576B1Feb 27, 2001
Process for preparing antiviral 2-phosponate nucleotide analogs
IAF BIOCHEM INT15 citations92
US6127540AOct 3, 2000
Antiviral compounds
IAF BIOCHEM INT26 citations92
US5587480ADec 24, 1996
Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IAF BIOCHEM INT56 citations92
US5532246AJul 2, 1996
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
IAF BIOCHEM INT35 citations92
US6605614B2Aug 12, 2003
[1,8] naphthyridine derivatives having antiviral activity
IAF BIOCHEM INT44 citations91
US6903224B2Jun 7, 2005
Substituted 1,3-oxathiolanes
IAF BIOCHEM INT33 citations88
US6358963B1Mar 19, 2002
Antiviral nucleoside analogues
IAF BIOCHEM INT7 citations74
US6545001B2Apr 8, 2003
Antiviral nucleoside analogues
IAF BIOCHEM INT3 citations63
VIROCHEM PHARMA INC
4 patentsUS6881741B2Apr 19, 2005
Compounds and methods for the treatment or prevention of Flavivirus infections
VIROCHEM PHARMA INC107 citations96
US6936629B2Aug 30, 2005
Compounds and methods for the treatment or prevention of flavivirus infections
VIROCHEM PHARMA INC51 citations91
US6887877B2May 3, 2005
Compounds and methods for the treatment or prevention of Flavivirus infections
VIROCHEM PHARMA INC45 citations91
US7402608B2Jul 22, 2008
Compounds and methods for the treatment or prevention of Flavivirus infections
VIROCHEM PHARMA INC37 citations90
SHIRE BIOCHEM INC
3 patentsUS6831174B2Dec 14, 2004
Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties
SHIRE BIOCHEM INC32 citations92
US7122693B2Oct 17, 2006
Acetaldehyde acetal compounds, their synthesis, and uses thereof
SHIRE BIOCHEM INC32 citations87
USRE39155EJul 4, 2006
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
SHIRE BIOCHEM INC1 citations42